Treating Hyperexcitability in AD With Levetiracetam
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to explore the relationship between cortical hyperexcitability,
abnormalities of brain network function, and cognitive dysfunction in human patients with AD
and whether administration of the antiepileptic medication levetiracetam (LEV) normalizes
these measures and improves cognition.